Day two shifts to automation and artificial intelligence, opening with a quality-culture case study, then an extended panel asking whether AI can transform pharmaceutical investigations, a Coherent Market Insights keynote projecting the Lab 5.0 market through 2033, and a CXO ecosystem panel.
Day 2’s conference theme — “Smart, Sustainable, AI-Driven Labs: Empowering the Future Workforce in the Pharma Industry” — is run in collaboration with the Indian Pharmaceutical Alliance (IPA), whose senior technical advisor, Dr. Rajiv Desai, moderates the day’s marquee session.
Light Pharma’s Pravin Kulkarni opens at 11:00 am with a case study on quality sustainability and quality culture, before an extended 90-minute panel takes up one of the more pointed questions on the conference agenda: whether artificial intelligence can shift pharmaceutical quality investigations from simply finding a cause to detecting a pattern. The panel draws together perspectives from a consulting CEO, a Sai Life Sciences chief quality officer, USP India’s site head, and a former Sun Pharma global quality and compliance vice-president — a spread that suggests the discussion will weigh AI’s promise against the compliance realities of regulated manufacturing.
The afternoon opens with a keynote from Coherent Market Insights’ Mohit Shrivastava — the fair’s Knowledge Partner — projecting the Indian laboratory-automation, informatics and AI market opportunity out to 2033 under the “Lab 5.0” framing. Shrivastava then moderates a 90-minute CXO panel bringing together leadership from Smilax Laboratories, Sapien Biosciences, Aragen Life Sciences and Garphi Biosciences to discuss innovation, digital laboratories and industry collaboration across India’s scientific ecosystem.
– Raja Aditya
Day 2 conference schedule
| Time | Session | Speaker(s) |
| 11:00 – 11:30 am | Leadership Insight Case Study: Empowering the Future — Way Forward for Quality Sustainability & Quality Culture | Pravin Kulkarni, Vice President, Light Pharma |
| 11:30 am – 1:00 pm | Panel: The AI Quality Investigator — Can AI Transform Pharmaceutical Investigations from “Finding the Cause” to “Finding the Pattern”? | Moderator Dr. Rajiv Desai (Indian Pharmaceutical Alliance); Dr. BM Rao (Qdot Associates); Dr. Damodharan Muniyandi (Sai Life Sciences); Dr. Girish Kapur (USP India); M. Gopi Reddy (QBC Consulting Partners); Pravin Kulkarni (Light Pharma) |
| 2:00 – 2:30 pm | Keynote: Lab 5.0 in India — Laboratory Automation, Informatics and AI Market Opportunity, 2026–2033 | Mohit Shrivastava, AVP Research and Consulting, Coherent Market Insights |
| 2:30 – 4:00 pm | CXO Panel: India’s Laboratory & Scientific Ecosystem — Accelerating Innovation through Advanced Analytical Technologies, Digital Laboratories, and Industry Collaboration | Moderator Mohit Shrivastava; Appasaheb Kandagal (Smilax Laboratories); Dr. Jugnu Jain (Sapien Biosciences); Dr. Ramesh Jagadeesan (Aragen Life Sciences); Venkat Kamalakar Bundla (Garphi Biosciences) |
